Geometric and dosimetric evaluation of the differences between rigid and deformable registration to assess interfraction motion during pelvic radiotherapy by White, I et al.
Contents lists available at ScienceDirect
Physics and Imaging in Radiation Oncology
journal homepage: www.elsevier.com/locate/phro
Original Research Article
Geometric and dosimetric evaluation of the differences between rigid and
deformable registration to assess interfraction motion during pelvic
radiotherapy
Ingrid White, Dualta McQuaid, Helen McNair, Alex Dunlop, Steven Court, Naomi Hopkins,
Karen Thomas, David Dearnaley, Shree Bhide, Susan Lalondrelle⁎
Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, United Kingdom
A B S T R A C T
Background and purpose: Appropriate internal margins are essential to avoid a geographical miss in intensity-modulated radiation therapy (IMRT) for endometrial
cancer (EC). This study evaluated interfraction target motion using rigid and non-rigid approximation strategies and calculated internal margins based on random
and systematic errors using traditional rigid margin recipes. Dosimetric impact of target motion was also investigated.
Materials and methods: Cone beam CTs (CBCTs) were acquired days 1–4 and then weekly in 17 patients receiving adjuvant IMRT for EC; a total of 169 CBCTs were
analysed. Interfraction motion for the clinical target volume vaginal vault and upper vagina (CTVv) was measured using bony landmarks and deformation vector field
displacement (DVFD) within a 1mm internal wall of CTVv. Patient and population systematic and random errors were estimated and margins calculated. Delivered
dose to the CTVv and organs at risk was estimated.
Results: There was a significant difference in target motion assessment using the different registration strategies (p < 0.05). DVFD up to 30mm occurred in the
anterior/posterior direction, which was not accounted for in PTV margins using rigid margin recipes. Underdosing of CTVv D95% occurred in three patients who had
substantial reductions in rectal volume (RV) during treatment. RV relative to the planning CT was moderately correlated with anterior/posterior displacement
(r= 0.6) and mean relative RV during treatment was strongly correlated with mean relative RV at CBCT acquired days 1–3 (r= 0.8).
Conclusion: Complex and extensive geometric changes occur to the CTVv, which are not accounted for in margin recipes using rigid approximation. Contemporary
margin recipes and adaptive treatment planning based on non-rigid approximation are recommended.
1. Introduction
External beam radiotherapy (EBRT) to the pelvic lymph nodes and
vaginal vault following hysterectomy reduces local recurrence in in-
termediate and high-risk endometrial cancer (EC) [1,2]. Compared to
3D conformal plans, intensity modulated radiotherapy (IMRT) in EC
reduces dose to the small bowel and bladder and enables better target
coverage and dose homogeneity [3,4]. This translates into the clinical
benefit of less acute and late gastrointestinal toxicity [5–7]. The tight
conformity and sharp dose gradients achieved with IMRT mean that
appropriate internal margins are essential to avoid a geographical miss.
The current assessment of IMRT plans and dose–volume histograms
(DVHs) is based on the radiotherapy planning CT (pCT), a single image
set taken at one point before the start of treatment. The dosimetry and
DVHs do not necessarily represent the actual dose delivered to the
target and organs at risk (OARs), because they do not account for
motion and geometric changes occurring during treatment. Target
motion can be evaluated geometrically or by measuring the impact that
target motion has on delivered dose. Previous studies of IMRT in EC
have largely focused on the magnitude of target motion. Rigid ap-
proximation has been studied to assess target motion, often with fidu-
cial or centre of mass measurement. Internal margins are then calcu-
lated based on recipes that assume these structures are rigid [8–15].
Non-rigid or deformable image registration (DIR) can account for mo-
tion at each point within a defined structure, potentially providing a
better representation of changing geometry compared to rigid methods.
DIR is necessary to accumulate the delivered dose in the context of
changing target and OARs geometry over a treatment course. This is
particularly relevant in the post-operative female pelvis where the
central vaginal vault target is subject to compression and displacement
by changes in the adjacent bladder and rectum. DIR is now commer-
cially available, but it is not in widespread clinical use in radiotherapy
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treatment planning and delivery. It is limited by the model used to
define the deformation, and its clinical application is challenging in the
pelvis where complex anatomical variation occurs. In particular, there
is difficulty accounting for tissue interfaces that are sliding such as the
rectum, and tissues such as the bladder which show substantial elastic
changes.
To our knowledge, no previous studies have investigated interfrac-
tion target motion using both rigid and non-rigid approximation stra-
tegies and no studies have evaluated the dosimetric impact of target
motion in EC. The first aim of this study was to evaluate and compare
interfraction target motion during IMRT for EC using rigid and non-
rigid approximation strategies as assessed on Cone beam CT (CBCT) and
to calculate internal margins based on the random (σ) and systematic
(Σ) error observed using traditional rigid margin recipes. The second
aim was to determine the dosimetric impact of target motion in EC
using dose accumulation.
2. Materials and methods
2.1. Patients and image data
Seventeen patients were identified who underwent adjuvant pelvic
IMRT following hysterectomy for EC from December 2011 to December
2012. Local protocol margins of 15mm superiorly and inferiorly and
10mm circumferentially were applied to the clinical target volume of
the vaginal vault and upper vagina (CTVv). All patients were treated
with 5–7 field IMRT single phase treatment including the CTVv and
pelvic lymph nodes to a dose of 45 Gy in 25 fractions, delivered over
5 weeks.
Each patient underwent a pCT in supine position with IV contrast.
Patients were instructed to drink 350ml water after complete bladder
voiding 1 hour before the pCT. There were no bowel preparation in-
structions. The pCT was acquired from the top of L4 to the perineum,
with a slice thickness of 2.5mm, in-plane resolution of 0.97mm pixels
and field of view (FOV) 500mm. Kv CBCT images were acquired (M20
kV mAs Elekta Synergy v5.4 Crawley UK) immediately before treatment
and an off-line correction protocol was used with Σ error based on bony
registration. In all patients CBCTs were acquired days 1–3 and weekly
thereafter unless there was an error of> 5mm, in which case they were
acquired more frequently. All images acquired were transferred to the
RayStation treatment planning system (TPS) (RayStation v6 Raysearch
Laboratories) for contour delineation, motion assessment, and dose
accumulation.
2.2. Target and organ at risk segmentation
The CTVv, rectum and bladder were manually contoured on each
pCT and CBCT image set. The rectum was contoured from the anor-
ectum junction to the rectosigmoid junction. Consensus delineations
were performed by experienced radiation oncologists (IW and SL).
Pearson’s correlation coefficient (r) was calculated to determine the
correlation between both bladder and rectal volumes with time-point
during treatment and target motion.
2.3. Image registration
Rigid registration between the pCT and each CBCT was defined by
treatment position, which was based on bony anatomy. DIR was per-
formed between the pCT and each CBCT using the Anaconda algorithm
[16] with the CTVv and rectum as controlling regions of interest. The
Anaconda algorithm expresses the registration problem as a non-linear
optimisation problem and uses a hybrid algorithm which combines both
a geometric and intensity-based approach [16]. The quality of DIR was
quantified by dice similarity coefficient (DSC) and mean distance to
agreement (MDA) of the CTVv and rectum contours, with the pCT re-
presenting the true contour. The CTVv mean DSC was 0.9 and MDA was
0.7 mm, the rectum DSC was 0.9 and MDA was 0.9 mm, all consistent
with good agreement. The quality of these registrations was deliber-
ately improved at the rectum and CTVv and would not be
representative of the quality of DIR at more peripherally located
structures.
2.4. Target motion assessment
Target motion was assessed using both rigid and non-rigid approx-
imation strategies. A 1mm internal wall of the CTVv was created and
sub-divided into halves to generate structures representing the right,
left, anterior and posterior walls of the CTVv (Fig. 1). This was moti-
vated by the deformable nature of the CTVv, which showed extrinsic
compression from the rectum posteriorly and the bladder anteriorly. We
assumed a smooth expansion of the contour edge and no sharp dis-
continuity of motion. It is possible that one part of the subdivision is
moving very differently to another part and overlap of the subdivisions
could lead to over or underestimation of motion, but providing there is
smooth contour expansion the impact this has on the determined target
motion should be minimal. To determine internal motion in different
directions only translations in the plane of interest were assessed. Rigid
assessment of target motion was estimated by translation of the most
extreme right, left, anterior and posterior positions of the CTVv struc-
ture, relative to the mid femoral head bony landmark. These mea-
surements were taken at each 2.5 mm slice on which the structure was
contoured and mean displacement in each direction was calculated
across all slices for each CBCT. Target motion assessment using non-
rigid approximation was achieved by calculating the mean deformation
vector field displacement (DVFD) of all voxel displacements within
each subdivision of the CTVv wall on each CBCT (Fig. 2). The mean
deformation vector field displacement for each CBCT was used to cal-
culate the mean and standard deviation (SD) voxel displacement within
each subdivision of the CTVv wall for each patient. The mean target
motion using both methods, calculated for each CBCT and each patient,
was compared using the Wilcoxon rank test. Population Σ and σ error
for internal target motion was calculated from the patient mean and SD
internal target motion for both assessment strategies.
Set up error was determined from bony displacement of the CBCT
with the reference pCT and population Σ and σ error set up error were
Fig. 1. Sub-division of CTVv for non-rigid assessment of internal motion; a)
Anterior and posterior wall and b) Right and left wall, both on axial view, c)
Anterior and posterior wall on sagittal view and d) Right and left wall on
coronal view. Anterior wall= blue, posterior= red, right= turquoise and
left= purple. (For interpretation of the references to colour in this figure le-
gend, the reader is referred to the web version of this article.)
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calculated. For the rigid approximation data, the van Herk formula
(2.5Σ+0.7σ) was used to calculate margins required to account for
observed internal motion and set up errors [17]. CTV-PTV margins to
encompass the population target motion and set-up error were de-
termined by combining the margins for target motion and set-up error
in quadrature [18].
2.5. Simulation of delivered dose
CBCT dose calculation was facilitated by bulk density assignment
[19]. Bulk density assignments were defined on CBCT, dividing the
image dataset into regions of air, lung, adipose, tissue, cartilage/bone
and high density. The corresponding mass densities (g/cm3) were used
for the dose calculations; air 0.00121, lung 0.26, adipose 0.95, tissue
1.05 and cartilage/bone 1.6. The clinically delivered plan was calcu-
lated on each CBCT and deformed to the pCT using the DIR. The de-
formed dose cubes were assigned weights according to the number of
fractions delivered between each consecutive CBCT acquisition. The
weighted deformed dose was summed and compared to the planned
dose as calculated on the pCT. The planned dose to the CTVv (D99,
D95, D50, D5 and D2), rectum (V40 Gy and V30 Gy) and bladder (mean
dose) was compared to the simulated delivered dose using the Wilcoxon
rank test. All statistical analyses were performed on GraphPad Prism 7
and p-values< 0.05 were considered statistically significant.
3. Results
3.1. Rigid and non-rigid assessment of target motion
A total of 169 CBCTs were analysed. The mean CTVv at baseline on
pCT was 47 cm3 (range, 25–72 cm3) and the maximal change in CTVv
CBCT volume relative to baseline was 43–129%. Target motion was
largest in anterior and posterior directions (Table 1). Based on mea-
sured motion using rigid approximation, the CTVv to PTV margins,
calculated for IMRT in EC without the use of daily online imaging, were
10mm in the right direction, 11mm in the left direction, 14mm
anteriorly and 12mm posteriorly, to ensure 95% of the prescribed dose
is delivered to the CTVv in 90% of patients. DVFD of up to 30mm
occurred in the anterior direction in 1 patient and anterior or posterior
DVFD>20mm were seen in a further 8 patients. In 15/17 (88%) of
patients (53/169 fractions) DVFD in the anterior/posterior directions
were greater than margins calculated using the rigid approximation
data and rigid margin recipes. In 16/17 (94%) of patients (60/169
fractions) DVFD in the left or right directions were larger than the
calculated margins. Fig. 3 shows the distribution of mean and standard
deviation (SD) target motion in individual patients and CBCTs for the
rigid and non-rigid approximation strategies. There was a statistically
significant difference in mean target motion using the different strate-
gies for anterior, posterior and right directions (p < 0.05).
3.2. Impact of rectal and bladder volume on target motion
Despite a bladder filling protocol to minimise changes in bladder
volume during treatment, there were substantial variations in some pa-
tients. The maximal change in CBCT bladder volume relative to baseline
was 9–260%. The maximal change in rectal volume (RV) relative to
baseline was 32–249%. There was weak but statistically significant cor-
relation between relative bladder volume and RV on CBCT and treatment
time point, with a trend towards smaller volumes later in treatment
(r=−0.3, p < 0.05 for bladder and r=−0.2, p < 0.05 for rectum).
Mean % RV change, relative to the pCT, in CBCT acquired days 1–3 was
strongly correlated with mean % RV change over all CBCT (r=+0.8)
and CBCT acquired from day 4 onwards (r=+0.7) both p < 0.01.
In both the rigid and non-rigid approximation data, RV change re-
lative to pCT was correlated with anterior and posterior target motion
and this was statistically significant. For the non-rigid approximation,
there was moderate to strong correlation r=−0.6 for posterior dis-
placement of posterior CTVv wall and r=+0.6 for anterior displace-
ment of anterior CTVv wall (both p < 0.01). For the rigid approx-
imation data correlation was weak to moderate, r=−0.3 and
r=+0.4 for posterior and anterior CTVv wall displacement in re-
spective directions (both p < 0.05). For the rigid approximation data,
bladder volume relative to pCT was very weakly correlated with ante-
rior wall displacement (r= 0.2, p < 0.05), but there was no correla-
tion with the non-rigid approximation data.
3.3. Dosimetric impact of target motion on simulated delivered dose
There were statistically significant differences in the planned and
delivered dose for all target CTVv dose constraints (Table 2). There was
underdosing of CTVv D95% in 3/17 (18%) of patients who did not
receive the target dose constraint of 42.8 Gy (D95% 40.7 Gy, 41.4 Gy
and 42.7 Gy). In these patients there was substantial reduction in RV
during treatment compared to the reference pCT (mean RV during
treatment, relative to baseline 51%, 58% and 61%), which resulted in
posterior displacement of the CTVv (Fig. 4). Seven patients (41%) had
underdosing of CTVv D50% which did not reach the dose constraint of
44.6–45.5 Gy. There were also statistically significant differences in
delivered dose for the rectum V30 Gy and the mean bladder dose
(Fig. 4). CTVv motion outside the target region occurred posteriorly in
both superior and inferior halves of the CTVv.
Fig. 2. CTVv motion assessment; a) Rigid approximation strategy, b) Non-rigid
approximation strategy.
Table 1
Target motion according to non-rigid and rigid approximation. Margins calculated for rigid approximation data to account for the observed errors using van Herk’s
formula and PTV margins calculated to encompass the population target motion and set-up error.
Movement DVF displacement (mm) Rigid translation (mm) Setup error (mm) Rigid data CTVv to PTV (mm)
Mean of mean Σ σ Range Mean of mean Σ σ Range Margin Σ σ Margin Margin
Right −2.7 2.5 2.4 –22.8–19.1 −0.5 1.9 2.2 −20.0–21.6 6.6 2.1 3.3 7.6 10.1
Left −1.4 2.2 2.6 −21.1–18.1 −1.5 2.9 2.2 −29.2–20.3 8.8 2.1 3.3 7.6 11.4
Anterior −2.5 3.4 4.0 −29.3–30 −0.4 4.1 3.8 −27.0–23.4 12.9 1.1 2.0 4.2 13.5
Posterior 1.0 4.0 3.9 −29.6–27.2 −1.0 3.9 3.1 −26.3–23.4 12.1 1.1 2.0 4.2 12.2
DVF=Deformation vector field.
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4. Discussion
We have demonstrated statistically significant differences in target
motion assessment of CTVv and OAR in IMRT for EC using rigid versus
non-rigid approximation. Normal tissue sparing with IMRT in EC is
limited by geometric changes in the CTVv target and OARs. Accurate
assessment of these changes is essential to generate appropriate mar-
gins and ensure adequate target coverage during treatment. The first
aim of this study was to evaluate target motion using both rigid and
non-rigid approximation strategies. To our knowledge, no studies have
compared this before. Non-rigid approximation generated larger esti-
mates of mean motion and σ error. Anterior/posterior target motion
was moderately correlated with RV change relative to pCT for both
motion assessment strategies, but correlation was stronger for the non-
rigid data. This compares to other studies using rigid registration,
which have only shown weak correlation between anterior/posterior
target motion and RV change [8,20].
Previous published data for target motion in EC has used rigid re-
gistration strategies and traditional margin recipes that assume these
targets are rigid. However, we know these targets are deformable
structures. Our data suggests that traditional rigid approximation
strategies do not reflect the geometric complexity and underestimate
the extent of motion. This results in generation of inadequate internal
margins. Over 85% of patients studied had DVFD in the anterior/pos-
terior and right/left direction, which were outside internal margins
calculated using the rigid approximation data and rigid margin recipes.
Non-rigid registration provides a much better representation of geo-
metric change and has been validated for robustness and reproduci-
bility [21]. The challenge now is to translate motion data acquired
through deformable registration strategies into new internal margins,
which improve target coverage and reduce normal tissue irradiation.
Both the rigid and non-rigid approximation data indicate that ani-
sotropic margins are required. Calculated margins using rigid margin
recipes are larger than the 10mm circumferential margins we presently
use clinically. Extent and variability in target CTVv motion was largest
in the anterior/posterior direction with displacements of up to 30mm
observed. This is consistent with other published studies [8–10,12].
The second aim of this study was to evaluate the dosimetric impact
of target motion by comparing the planned dose with the simulated
delivered dose. This has not been evaluated previously in patients re-
ceiving external beam radiotherapy for EC. We found statistically sig-
nificant differences in the planned and simulated delivered dose. There
was underdosing of the target CTVv D95% in three patients and un-
derdosing of D50% in seven patients. Studies evaluating the dosimetric
Fig. 3. Boxplots showing the distribution of mean and standard deviation (SD) target motion in individual patients and CBCTs for the rigid and non-rigid ap-
proximation strategies. Horizontal bars, boxes and whiskers represent mean, 5th, 95th percentiles, minimum and maximum.
Table 2
Summary of dosimetric results for CTV and OAR planned and delivered dose.
Dose constraint Planned dose (Gy) Delivered dose (Gy) p-value
Mean (SD) Range Mean (SD) Range
CTVv D95% 43.9 (0.4) 43.0–44.4 43.4 (1.1) 40.7–45.0 0.02
CTVv D99% 43.5 (0.3) 42.7–44.0 43.0 (1.2) 39.5–44.6 0.04
CTVv D50% 45.1 (0.3) 44.6–45.7 44.5 (0.7) 42.9–45.7 < 0.01
CTVv D5% 46.3 (0.4) 45.6–47.1 45.5 (0.7) 44.0–46.8 < 0.01
CTVv D2% 46.6 (0.4) 45.9–47.3 45.7 (0.7) 44.2–47.0 < 0.01
Rectum V40 Gy 0.6 (0.2) 0.3–0.9 0.5 (0.3) 0.0–0.9 0.35
Rectum V30 Gy 0.8 (0.4) 0.7–1.0 0.8 (0.1) 0.6–1.0 < 0.01
Bladder mean dose 37.5 (2.4) 31.3–41.4 37.7 (2.5) 31.3–42.4 0.04
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advantage of IMRT have not taken target and OAR geometric change
into account and do not necessarily reflect the actual delivered dose.
They may therefore under or over-estimate target coverage and OAR
sparing. A previous study has evaluated dose accumulation using rigid
and non-rigid deformable registration strategies in 19 patients receiving
3 or 5 fraction brachytherapy to the vaginal vault for EC [22]. They also
found a statistically significant difference in the delivered dose to the
bladder, but in comparison to our results they did not find a significant
difference in the dose delivered to the rectum. They did not evaluate the
dose delivered to the CTVv. DIR can account for the deformable nature
of the CTVv, rectum and bladder, which makes it attractive for dose
accumulation in the pelvis. But there are limitations and challenges in
using DIR for dose accumulation. Large geometric changes in pelvic
anatomy between image sets and difficulty interpreting sliding tissue
interfaces can cause registration errors, and the image registration al-
gorithm itself is limited by the model used to describe the deformation.
These registration uncertainties lead to dose mapping uncertainty and
even a very small registration error can lead to substantial error in dose
accumulation at sites of sharp dose gradient or geometric uncertainty,
such as those that occur between the target CTVv and the rectum. We
quantitatively evaluated the registration error using DSC and MDA,
which were within tolerance in keeping with the AAPM Task Group 132
report [23]. Solutions to estimate the impact on the dose distribution
from uncertainties in the DIR algorithm have been presented [24], but
there is no consensus on how this should be achieved and this was not
further evaluated in our study.
There were no specific rectal filling instructions at pCT or during
treatment and substantial variation in rectal filling was observed. We
found moderate to strong correlation between RV and target anterior/
posterior motion (r= 0.6) and patients who had a rectal diameter>
50mm at pCT had underdosing of CTVv D95%. In two patients with
underdosing of CTVv D95%, anterior/posterior rectal diameter at pCT
measured 56mm and 52mm, and there was substantial reduction in RV
during treatment compared to the reference CT, which resulted in
posterior displacement of the CTVv. The 3rd patient with underdosing
of CTVv D95% also had posterior displacement of CTVv during treat-
ment due to reduced RV, but this was not predictable based on rectal
diameter at pCT, which was 36mm. In all 3 patients with underdosing
of CTVv D95%, RVs of less than 50% of the RV at pCT were seen within
the first week of treatment. Anticipation of posterior displacement by
limiting rectal diameter at pCT or increasing posterior margins in pa-
tients with large rectal diameter has been suggested. In our study a
threshold of< 50mm rectal diameter would identify 2/3 patients with
clinical underdosing of target, but rectal diameter was a poor surrogate
for RV at pCT and RV variation during treatment. For example, 1 pa-
tient with rectal diameter of 49mm at pCT had very stable RV
throughout treatment with no underdosing of the target. We did find
mean RV change, relative to the pCT, in CBCT acquired days 1–3 was
strongly correlated with mean % RV change over all CBCT (r=+0.8)
and CBCT acquired day 4 onwards (r=+0.7) both p < 0.01. This
suggests that patients who could benefit from margin adaptation can be
identified within the first week of treatment.
In a study including 15 post-operative cervix and endometrial pa-
tients, the impact of bladder and rectal filling on organ dose was
evaluated [25]. Patients had two pCTs, one with an empty bladder and
rectum and the second following bladder and rectum filling. There was
no reduction in integral rectal dose with increased rectal filling. This
compares to a study in 92 patients who received brachytherapy to the
vaginal vault where there was a significant positive correlation between
rectal volume and Dmax, D0.1cc and D1cc and D2cc [26]. In a study of 10
prostate patients, contouring the entire rectum, compared to contouring
the proximal and distal rectal volumes separately, led to significantly
increased dose to the distal rectum [27]. This increased for patients
with large rectal volumes at pCT with a mean increase in dose of
31% ± 19 for D50.
RV variation and the range of anterior/posterior target motion is
difficult to predict. Rectal filling strategies to reduce RV variation such
as regular use of laxatives have been studied [28–31], but in gynae-
cological radiotherapy these have failed to show benefit [30]. Taku
et al. evaluated the use of rectal balloon and found that smaller 7mm
anterior/posterior margins were required as measured using fiducial
makers and rigid registration techniques [13].
Based on the results presented here we suggest some strategies to
improve IMRT in EC. Population based margins using non-rigid ap-
proximation and non-rigid margin recipes should be developed.
Accounting for variations in target deformation through the whole
volume may reduce the incidence of geographic miss and dose to OAR.
This should be coupled with daily CBCT imaging to identify patients at
most risk of RV variation during treatment. Our study suggests that
these patients, who may require margin adaptation, can be identified
within the first week of treatment. IMRT techniques take full advantage
of normal tissue sparing whilst maintaining adequate target coverage,
but additional adaptive strategies need to be developed. We suggest a
plan selection strategy with variable anterior/posterior margins, which
is where the largest variation in target motion was observed. Unless
adaptive therapy is used on the basis of our rigid approximation ana-
lysis, margins of 11mm in right and left directions, 14mm anteriorly
and 12mm posteriorly are required in IMRT for EC without daily online
imaging.
Limitations of our study include the relatively poor soft tissue
contrast of CBCT for contour delineation and lack of imaging data for
each treatment fraction. To reduce contour delineation variability and
error all contouring was performed by the same experienced observer
and reviewed by a second senior radiation oncologist. The DIR and dose
accumulation results were driven by these contoured structures so de-
lineation error will affect their accuracy. A comprehensive analysis of
interobserver contouring variability was not addressed in this study.
Previous studies have used MRI or diagnostic CT to evaluate target
Fig. 4. Sagittal images of patient with significant under dosing of CTVv; a) Planned dose with CTVv in pink, (b-e) CTVv geometry at treatment CBCTs (blue)
compared with CTVv geometry at planning CT (pink) for weeks 1–4 respectively, (f) Simulated delivered dose with CTVv in blue. (For interpretation of the references
to colour in this figure legend, the reader is referred to the web version of this article.)
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motion, but for dose accumulation CBCT was necessary to reflect
patient target and OAR geometry at the time of treatment.
In conclusion, significant differences in target motion assessment
were seen between rigid and non-rigid registration strategies with non-
rigid approximation demonstrating complex and extensive geometric
changes to the CTVv, which were not accounted for in margin recipes
using rigid registration. Target and OAR motion was observed that
exceeded the motion accounted for within our standard clinical margins
and margins calculated using rigid margin recipes. This resulted in
underdosing in some patients. RV relative to the pCT was moderately
correlated with anterior/posterior displacement and could be predicted
from CBCTs acquired days 1–3. EC patients need daily on-line image
guidance. Contemporary margin recipes and adaptive treatment plan-
ning based on non-rigid approximation are recommended.
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